| Biotest (Schweiz) AG - Hepatect CP, Infusionslösung |
| 00488 | | 02 | | Hepatect CP | | Infusionslösung | | J06BB04 | | Hepatitis B Immunoglobulin | | 28.01.2002 | | |
|
| Composition |
| immunoglobulinum humanum hepatitidis B 50 U.I. ut proteinorum plasmatis humani solutio 50 mg corresp. immunoglobulinum humanum normale min. 96 %, immunoglobulinum humanum A max. 2 mg, glycinum, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.023 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Infusion solution | | | | | | | | Active Agent | Dose |
|---|
| Immunoglobulinum Humanum Hepatitidis B | 50 UI/ml |
| | BAG: Active Agent | Dose |
|---|
| Immunoglobulinum Humanum Hepatitidis B | 5000 UI |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Glycin | | | Immunoglobulinum Humanum A | 2 mg/ml | | Sodium Hydroxide | |
| |
|
|
